Company Profile
Walteq Inc is a privately held company that markets laboratorial equipment and supplies for biomedical, mineral, and oil research and development. Walteq Inc has development and manufacturing bases and partners in China. For China market, we focus on helping institutes and universities to speed up their research by sourcing novel technologies and devices from world wide, especially the United States.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aS,13aR,13bR,13cS)- |
1H,5H,10H-Dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one,dodecahydro-,(7aS,13aR,13bR,13cS)-;Matrine;Matridin-15-one;(7aS,13aR,13bR,13cS)-Dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one;(+)-Matrine;α-Matrine;NSC 146051;NSC 318810;Vegard;Bioca;Matrine-fluensulfone mixt.;569-23-3;21914-56-7 |
519-02-8 | - / 98.0% | Inquiry |
24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oicacid, 3-hydroxy-9,13-dimethyl-2-oxo-, (9b,13a,14b,20a)- |
24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oic acid,3-hydroxy-9,13-dimethyl-2-oxo-,(9β,13α,14β,20α)-;D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid,3-hydroxy-2-oxo-,(20α)-;24-Nor-D:A-friedooleana-1(10),3,5,7-tetraen-29-oic acid,3-hydroxy-2-oxo-;(9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid;Celastrol;Tripterin;2-Picenecarboxylic acid,1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-,[2R-(2α,4aβ,6aβ,12bβ,14aα,14bβ)]-;2-Picenecarboxylic acid,1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-,(2R,4aS,6aS,12bR,14aS,14bR)-;NSC 70931;UI1590 |
34157-83-0 | - / 98.0% | Inquiry |
Artemisinin |
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one,octahydro-3,6,9-trimethyl-,(3R,5aS,6R,8aS,9R,12S,12aR)-;3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one,octahydro-3,6,9-trimethyl-,[3R-(3α,5aβ,6β,8aβ,9α,12β,12aR*)]-;(3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one;Qing Hau Sau;Artemisinin;Arteannuin;Qinghaosu;Qing Hau Su;(+)-Artemisinin;Qinghosu;(+)-Arteannuin;(+)-Qinghaosu;Huanghuahaosu;Artemisine;QHS;NSC 369397;Artemef;Artemisinine;HC 101A;ARTIVeda;PulmoHeal;91487-93-3 |
63968-64-9 | - / 99.0% | Inquiry |
Baicalin |
β-D-Glucopyranosiduronic acid,5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl;Baicalin;5,6-Dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl β-D-glucopyranosiduronic acid;Baicalein 7-glucuronide;Baicalein 7-O-β-D-glucuronide;Baicalein 7-O-glucuronide;100647-26-5;27462-75-5;31564-28-0;912850-49-8 |
21967-41-9 | - / 98.0% | Inquiry |
Crotaline |
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,(3R,4R,5R,13aR,13bR)-;20-Norcrotalanan-11,15-dione,14,19-dihydro-12,13-dihydroxy-,(13α,14α)-;Monocrotaline;2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine,20-norcrotalanan-11,15-dione deriv.;(3R,4R,5R,13aR,13bR)-4,5,8,10,12,13,13a,13b-Octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione;Monocrotalin;(-)-Monocrotaline;2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,[3R-(3R*,4R*,5R*,13aR*,13bR*)]-;NSC 28693;30331-79-4;48197-27-9 |
315-22-0 | - / 99.0% | Inquiry |
Oridonin |
Kaur-16-en-15-one,7,20-epoxy-1,6,7,14-tetrahydroxy-,(1α,6β,7α,14R)-;Kaur-16-en-15-one,7α,20-epoxy-1α,6β,7,14-tetrahydroxy-,(14R)-;Oridonin;6,11b-(Epoxymethano)-6a,9-methano-1H-cyclohepta[a]naphthalene,kaur-16-en-15-one deriv.;(1α,6β,7α,14R)-7,20-Epoxy-1,6,7,14-tetrahydroxykaur-16-en-15-one;Isodonol;NSC 250682;Oridonine;(-)-Oridonin;18288-82-9;2305818-70-4 |
28957-04-2 | - / 98.0% | Inquiry |
CONTACT INFORMATION
Sign In for Details